139 related articles for article (PubMed ID: 26436799)
1. [Hepatitis E virus seroprevalence: a reappraisal].
Covarrubías N; Hurtado C; Díaz A; Mezzano G; Brahm J; Venegas M
Rev Chilena Infectol; 2015 Aug; 32(4):482-4. PubMed ID: 26436799
[TBL] [Abstract][Full Text] [Related]
2. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates.
Wenzel JJ; Preiss J; Schemmerer M; Huber B; Jilg W
J Infect Dis; 2013 Feb; 207(3):497-500. PubMed ID: 23148290
[TBL] [Abstract][Full Text] [Related]
3. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries.
Bendall R; Ellis V; Ijaz S; Ali R; Dalton H
J Med Virol; 2010 May; 82(5):799-805. PubMed ID: 20336757
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of hepatitis E virus in Hong Kong, 2008-2009.
Chiu DM; Chan MC; Yeung AC; Ngai KL; Chan PK
J Med Virol; 2013 Mar; 85(3):459-61. PubMed ID: 23239426
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of Hepatitis E Virus Antibodies in Portuguese Children.
Oliveira R; Mesquita JR; Pereira S; Abreu-Silva J; Teixeira J; Nascimento MSJ
Pediatr Infect Dis J; 2017 Jul; 36(7):623-626. PubMed ID: 28033239
[TBL] [Abstract][Full Text] [Related]
6. Sero-epidemiology of hepatitis E virus (HEV) in urban and rural children of North India.
Mathur P; Arora NK; Panda SK; Kapoor SK; Jailkhani BL; Irshad M
Indian Pediatr; 2001 May; 38(5):461-75. PubMed ID: 11359972
[TBL] [Abstract][Full Text] [Related]
7. Estimation of the hepatitis E assay-dependent seroprevalence among Croatian blood donors.
Miletić M; Vuk T; Hećimović A; Stojić Vidović M; Jemeršić L; Jukić I
Transfus Clin Biol; 2019 Nov; 26(4):229-233. PubMed ID: 31277986
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis E virus seroprevalence in blood donors in a university hospital in Chile].
Covarrubias N; Naveas P; Miranda J; Hurtado C; Vera DB; Larrondo M; Brahm J; Venegas M
Rev Chilena Infectol; 2018 Aug; 35(4):455-457. PubMed ID: 30534936
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis E virus antibodies in children in Germany.
Krumbholz A; Neubert A; Joel S; Girschick H; Huppertz HI; Kaiser P; Liese J; Streng A; Niehues T; Peters J; Sauerbrey A; Schroten H; Tenenbaum T; Wirth S; Zell R; Sauerbrei A
Pediatr Infect Dis J; 2014 Mar; 33(3):258-62. PubMed ID: 24168981
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of IgG antibodies to hepatitis E in urban and rural southern India.
Vivek R; Chandy GM; Brown DW; Kang G
Trans R Soc Trop Med Hyg; 2010 Apr; 104(4):307-8. PubMed ID: 19729178
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of antibodies to hepatitis A and E viruses in pediatric age groups in Turkey.
Colak D; Ogunc D; Gunseren F; Velipasaoglu S; Aktekin MR; Gültekin M
Acta Microbiol Immunol Hung; 2002; 49(1):93-7. PubMed ID: 12073829
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis E virus infection in Brazil: results of laboratory-based surveillance from 1998 to 2013.
Passos-Castilho AM; de Sena A; Reinaldo MR; Granato CF
Rev Soc Bras Med Trop; 2015; 48(4):468-70. PubMed ID: 26132499
[TBL] [Abstract][Full Text] [Related]
13. [Serological antibodies comparison of a hepatitis E outbreak].
Tan CR; Bao ZY; Sun HY; Hu M; Chen Y; Chen M; Zhang M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):35-8. PubMed ID: 16201469
[TBL] [Abstract][Full Text] [Related]
14. HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kits.
Yaşar O; Karatayli E; Cengiz G; Kızılpınar M; Yurdcu E; Albayrak R; Güven A; Arslan Ö; Karahan C; Otlu B; Güdücüoğlu H; Gökahmetoğlu S; Berk E; Kirişci Ö; Sertöz R; Yurdaydin C; Bozdayi AM; Karatayli SC
J Med Virol; 2019 Dec; 91(12):2174-2181. PubMed ID: 31403185
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence and risk factors of hepatitis E virus infection among children in China.
Meng QF; You HL; Wang WL; Zhou N; Dong W; Cong W
J Med Virol; 2015 Sep; 87(9):1573-7. PubMed ID: 25940435
[TBL] [Abstract][Full Text] [Related]
16. [Development of a diagnostic kit of enzyme-linked immunoassay for detecting serum anti-hepatitis E virus IgG].
Zhuang H; Cui Y; Zhu W
Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):315-7. PubMed ID: 11769630
[TBL] [Abstract][Full Text] [Related]
17. Swine is a possible source of hepatitis E virus infection by comparative study of hepatitis A and E seroprevalence in Thailand.
Sa-nguanmoo P; Posuwan N; Vichaiwattana P; Wutthiratkowit N; Owatanapanich S; Wasitthankasem R; Thongmee T; Poovorawan K; Theamboonlers A; Vongpunsawad S; Poovorawan Y
PLoS One; 2015; 10(4):e0126184. PubMed ID: 25927925
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis E virus epidemiology in adult population in Edirne province, Turkey].
Eker A; Tansel O; Kunduracilar H; Tokuç B; Yuluğkural Z; Yüksel P
Mikrobiyol Bul; 2009 Apr; 43(2):251-8. PubMed ID: 19621610
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence and Incidence of hepatitis E in blood donors in Upper Austria.
Fischer C; Hofmann M; Danzer M; Hofer K; Kaar J; Gabriel C
PLoS One; 2015; 10(3):e0119576. PubMed ID: 25751574
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis E is a cause of unexplained hepatitis in The Netherlands.
Waar K; Herremans MM; Vennema H; Koopmans MP; Benne CA
J Clin Virol; 2005 Jun; 33(2):145-9. PubMed ID: 15911430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
